Novavax, Inc. (NVAX)
8.25
+0.38
(+4.83%)
USD |
NASDAQ |
Feb 06, 16:00
8.36
+0.11
(+1.33%)
After-Hours: 07:27
Novavax Shareholders Equity (Quarterly) : -156.67M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | -- |
| Pfizer Inc. | -- |
| Moderna, Inc. | 9.33B |
| Plus Therapeutics, Inc. | 5.054M |
| INVO Fertility, Inc. | 5.849M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.180B |
| Total Liabilities (Quarterly) | 1.337B |
| Debt to Equity Ratio | -1.603 |
| Current Ratio | 2.267 |
| Net Debt Paydown Yield | -0.25% |